Production of CGMP-Grade Lentiviral Vectors.
作者信息
Ausubel Lara J, Hall Christine, Sharma Anupriya, Shakeley Rebecca, Lopez Patricia, Quezada Valerie, Couture Sylvana, Laderman Kenneth, McMahon Ross, Huang Patricia, Hsu David, Couture Larry
出版信息
Bioprocess Int. 2012 Feb;10(2):32-43.
Abstract
摘要
相似文献
1
Production of CGMP-Grade Lentiviral Vectors.
Bioprocess Int. 2012 Feb;10(2):32-43.
2
Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
Mol Ther Methods Clin Dev. 2019 Nov 26;17:58-68. doi: 10.1016/j.omtm.2019.11.011. eCollection 2020 Jun 12.
3
Large-scale production means for the manufacturing of lentiviral vectors.
Curr Gene Ther. 2010 Dec;10(6):474-86. doi: 10.2174/156652310793797748.
4
Production of lentiviral vectors for transducing cells from the central nervous system.
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
5
Optimized Production of Lentiviral Vectors for CAR-T Cell.
Methods Mol Biol. 2020;2086:69-76. doi: 10.1007/978-1-0716-0146-4_5.
6
Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Hum Gene Ther. 2011 Oct;22(10):1269-79. doi: 10.1089/hum.2010.143. Epub 2011 Jun 13.
7
Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
J Gene Med. 2004 Nov;6(11):1197-205. doi: 10.1002/jgm.623.
8
Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Int J Med Sci. 2015 May 15;12(5):407-15. doi: 10.7150/ijms.11270. eCollection 2015.
9
Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer.
J Gene Med. 2009 Aug;11(8):670-8. doi: 10.1002/jgm.1353.
10
Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs.
Sci Rep. 2020 Mar 24;10(1):5291. doi: 10.1038/s41598-020-62167-9.
引用本文的文献
1
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphoma.
J Immunother Cancer. 2025 Apr 9;13(4):e010709. doi: 10.1136/jitc-2024-010709.
2
Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing.
Viruses. 2024 Jul 29;16(8):1216. doi: 10.3390/v16081216.
3
Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line.
Mol Ther Methods Clin Dev. 2024 May 7;32(2):101264. doi: 10.1016/j.omtm.2024.101264. eCollection 2024 Jun 13.
4
Mechanisms and Delivery of tRNA Therapeutics.
Chem Rev. 2024 Jun 26;124(12):7976-8008. doi: 10.1021/acs.chemrev.4c00142. Epub 2024 May 27.
5
Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams.
ACS Synth Biol. 2024 Feb 16;13(2):466-473. doi: 10.1021/acssynbio.3c00682. Epub 2024 Jan 24.
6
An optimized HEK293T cell expansion protocol using a hollow-fiber bioreactor system.
Biol Methods Protoc. 2023 Sep 13;8(1):bpad018. doi: 10.1093/biomethods/bpad018. eCollection 2023.
7
Implementation of Novel Affinity Ligand for Lentiviral Vector Purification.
Int J Mol Sci. 2023 Feb 8;24(4):3354. doi: 10.3390/ijms24043354.
8
A feasibility study of different commercially available serum-free mediums to enhance lentivirus and adeno-associated virus production in HEK 293 suspension cells.
Cytotechnology. 2022 Dec;74(6):635-655. doi: 10.1007/s10616-022-00551-1. Epub 2022 Oct 25.
9
How promising are HIV-1-based virus-like particles for medical applications.
Front Cell Infect Microbiol. 2022 Oct 7;12:997875. doi: 10.3389/fcimb.2022.997875. eCollection 2022.
10
Modelling urea cycle disorders using iPSCs.
NPJ Regen Med. 2022 Sep 26;7(1):56. doi: 10.1038/s41536-022-00252-5.
本文引用的文献
1
A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson's disease.
Hum Gene Ther. 2011 Mar;22(3):357-69. doi: 10.1089/hum.2010.142. Epub 2011 Feb 10.
2
Large-scale production means for the manufacturing of lentiviral vectors.
Curr Gene Ther. 2010 Dec;10(6):474-86. doi: 10.2174/156652310793797748.
3
Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.
Hum Gene Ther. 2011 Mar;22(3):343-56. doi: 10.1089/hum.2010.060. Epub 2011 Mar 7.
4
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328.
5
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.
Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931.
6
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242.
7
Lentiviral vectors in clinical trials: Current status.
Curr Opin Mol Ther. 2009 Oct;11(5):554-64.
8
Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection.
Blood. 2009 May 21;113(21):5104-10. doi: 10.1182/blood-2008-11-191049. Epub 2009 Mar 13.
9
Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells.
Methods Mol Biol. 2008;433:287-299. doi: 10.1007/978-1-59745-237-3_18.
10
Production of retroviral vectors for clinical use.
Methods Mol Biol. 2008;433:17-32. doi: 10.1007/978-1-59745-237-3_2.
Zotero 插件